ADORA2A and Parkinson disease: ZM241385 is one of the selective A2AR antagonist and it has been used as a reference drug in many studies for A2ARs. Inhibition of A2ARs shows neuro-protection effect and it is proposed as an alternative non-dopaminergic strategy for the treatment of Parkinson’s disease.